DOJ is backing AbbVie in its battle to overturn a Colorado law that prohibits pharmaceutical companies from placing restrictions on the 340B drug discount program.
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...
HRSA extends comment period on 340B rebate proposal to April 20, allowing hospitals more time to submit detailed feedback.
Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in ...
Feds back AbbVie Colorado 340B fight, arguing state law conflicts with federal 340B program in a key 10th Circuit appeal.
The U.S. District Court for the District of Hawaii Feb. 23 denied a preliminary injunction requested by AstraZeneca in a case ...
When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...
Virginia state lawmakers who are tired of waiting are taking matters into their own hands during this year’s legislative ...
The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...
Claims by big hospital systems that the 340B Drug Pricing Program is “doing exactly what Congress intended” (“Comment: Hospitals staying true to Congress’ drug discounts,” The Herald, Feb. 14) ignore ...
Tennessee’s law prohibiting prescription drug manufacturers from imposing limits on pharmacies participating in the 340B drug discount program doesn’t violate federal law or the US Constitution, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results